| |
Tanya
Das, Ph.D.
List of publications in reverse
chronological order
Peer
reviewed journals
1.
Chakrabarty J, Banerjee S, Roy P, Bhattacharyya S,
Hossain D
Md. S,
Adhikary A,
Chattopadhyay S, Das T and Sa G.
Gain of
cellular adaptation due to prolong p53 impairment leads to functional
switch-over from p53 to p73 during DNA damage in acute myeloid leukemia
cells. J. Biol. Chem. (In press) (2010)
2.
Lahiry L, Saha B, Chakraborty J,
Adhikary
A, Banerjee S, Das K, Sa G and Das T. Theaflavins target Fas/caspase-8
and Akt/pBad
pathways to induce apoptosis in p53-mutated human breast cancer cells.
Carcinogenesis 31, 259-68 (2010)
3.
Adhikary
A, Mohanty S, Lahiry L, Hossain D Md. S, Chakraborty S and Das T
Theaflavins retard human breast cancer cell migration by inhibiting NF-kB
via p53-dependent ROS generation.
FEBS Letts. 584,
7-14 (2010)
4.
Bhattacharyya S,
Hossain D Md. S,
Mohanty S, Sen GS, Chattopadhyay S, Banerjee S, Chakraborty J, Das K, Sarkar
D, Das T
and Sa G. Curcumin reverses T cell-mediated adaptive immune dysfunctions in
tumor‐bearing host.
Cell. Mol. Immunol.
7,
306-15 (2010)
5.
Chattopadhyay S, Bhattacharyya S, Saha B, Chakrabarty J, Mohanty S,
Hossain DMS,
Banerjee
S, Das K, Sa G and Das T. Tumor-shed PGE2 impairs IL2Rgc-signaling
to inhibit CD4+ T cell survival: Regulation by theaflavins.
PLoS One 4, e7382 (2009)
6.
Chatterjee S, Mookerjee A, Mookerjee Basu J, Chakraborty P, Ganguly A,
Adhikary A, Mukhopadhyay D, Banerjee R, Ashraf M, Biswas J, Das PK, Sa G,
Chatterjee M, Das T and Chaudhuri SK. CuNG, a novel copper complex,
modulates drug resistant tumor associated macrohages to reprogram T cells to
elicit anti-tumor response. PLoS One 4,
e7048 (2009)
7.
Sa G,
Das T, Moon C, Hilston CM, Rayman PA, Rini BI, Tannenbaum CS, Finke JH.
GD3, an Overexpressed Tumor-Derived Ganglioside, Mediates the Apoptosis of
Activated but not Resting T Cells. Cancer
Res.
69, 3095-104, 2009 [Sa
G and Das T
both contributed equally to this paper].
8.
Lahiry L, Saha B, Chakraborty J, Bhattacharyya S, Chattopadhyay S,
Choudhuri T, Mandal D, Bhattacharyya A, Sa G and
Das T.
Contribution of p53-mediated transcription-dependent pathway in mammary
epithelial carcinoma cell apoptosis by theaflavins. Apoptosis
13, 771-81 (2008)
9.
Das T,
Sa G, Paszkiewicz-Kozik E, Hilston C, Molto L, Rayman P, Biswas K, Kudo D,
Bukowski RM, Finke JH and Tannenbaum C. Tumors Induce T Cell Apoptosis
Through Receptor-Dependent and Receptor-Independent Pathways. J.
Immunol. 180,
4687-96 (2008)
10.
Das T,
Sa G, Hilston C, Kudo D, Rayman P, Biswas K, Molto L, Bukowski R, Rini B,
Finke JH and Tannenbaum C. GM1 and TNFa, overexpressed in renal cell
carcinoma, synergize to induce T cell apoptosis. Cancer Research
68, 2014-23
(2008)
11.
Sa G,
Das T. Anti cancer effects of curcumin: cycle of life and death.
Cell Div.
3, 14 (2008)
12.
Bhattacharyya A, Mandal D, Lahiry L, Bhattacharyya S, Chattopadhyay S, Ghosh
UK, Sa G and Das T. Black Tea-Induced Amelioration of Hepatic
Oxidative Stress through Antioxidative Activity in EAC-Bearing Mice. J
Environ Pathol Toxicol Oncol.
26, 245-54 (2007)
13.
Bhattacharyya S, Mandal D, Saha B, Sen GS, Das T and Sa G. Curcumin
prevents tumor-induced T cell apoptosis through Stat-5a-mediated Bcl-2
induction. J Biol Chem. 282,
15954-64 (2007)
14.
Mandal D,
Bhattacharyya S, Lahiry L, Chattopadhyay S, Sa G and Das T.
Black tea-induced decrease in IL-10 and TGF-b
of tumor cells promotes Th1/Tc1 response in tumor-bearer. Nutrition
Cancer 58,
213-21 (2007)
15.
Raval G,
Biswas S, Rayman P, Biswas K, Sa G, Ghosh S, Thornton M, Hilston C, Das T,
Bukowski R, Finke
J and Tannenbaum CS. TNF-α Induction of GM2 Expression on Renal Cell
Carcinomas Promotes T cell Dysfunction. J Immunol.
178, 6642-522
(2007)
16.
Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L, Finke JH,
Tannenbum CS, Das T and Sa G. Tumor-induced oxidative stress perturbs
NFkB
activity augmenting TNFa-mediated
T cell death: Protection by curcumin. Cancer Research. 67,
362-70 (2007)
17.
Chattopadhyay S, Saha B, Mandal D, Sa G &
Das T.
Black tea: A Review. In:
Economic
Crisis in Tea Industry: Strategies for Scientific Management.
(Ed: Dr. F. Rahman and Dr. Peter Baker). ISTS Book 3 of the Book series
Global
Advances in Tea Science.
Studium Press LLC, Houston Texas, USA. Chapter 34, (2007)
18.
Dasgupta
R, Saha I, Pal S, Bhattacharyya A, Sa G, Nag TC, Das T
and Maiti BR. Immunosuppression, hepatotoxicity and depression
of antioxidant status by arecoline. Toxicology 227:94-104,
2006 [Das T & Maity BR both are corresponding authors in this
paper]
19.
Das T,
Sa G and Siddiqi M. Potential targets of tea polyphenols in cancer
prevention: significance in angiogenesis, metastasis and apoptosis as well
as in protection of host defense system. In: Protective effects of tea
on human health (Eds. J Weisberger, N K Jain and M Siddiqi) Cabi
London, 76-90, 2006.
20.
Biswas K,
Richmond A , Rayman P, Biswas S, Thornton M, Sa G, Das T, Zhang R,
Chahlavi A, Tannenbaum CS, Novick A, Bukowski R and Finke JH. GM2 Expression
in renal cell carcinoma: Potential role in tumor-induced immune dysfunction.
Cancer Research. 66:6816-25, 2006.
21.
Mookerjee
A, Mookerjee Basu J, Dutta P, Majumder S, Bhattacharyya S, Biswas J, Pal S,
Mukherjee P, Raha S, Baral RN, Das T, Efferth T, Sa G, Roy S,
Choudhuri SK. Overcoming drug resistant cancer by a newly developed copper
chelate through host protective cytokine mediated apoptosis. Clinical
Cancer Research 12:4339-49, 2006 .
22.
Bhattacharyya A, Lahiry L, Mandal D, Sa G and Das T.
Black tea induces tumor cell apoptosis by Bax translocation, loss in
mitochondrial transmembrane potential, cytochrome c release and caspase
activation. Int. J. Cancer 117:308-15, 2005.
23.
Mandal D,
Bhattacharyya A, Lahiry L, Bhattacharyya S, Sa G and Das T.
Tumor-induced thymic involution via Inhibition of IL-7Ra
and its JAK-STAT signaling pathway: Protection by Black Tea. Int.
Immunopharmacol. 6:433-44,
2005.
24.
Pal S,
Bhattacharya S, Choudhuri T, Datta GK, Das T and Sa G. Amelioration
of immune cell number depletion and potentiation of depressed detoxification
system of tumor-bearing mice by curcumin. Cancer Detection Prevention,
29:470-8, 2005.
25.
Mandal D, Bhattacharyya A, Lahiry L, Sa G and
Das T.
Failure in peripheral immuno-surveillance due to thymic atrophy: Importance
of thymocyte maturation and apoptosis in adult tumor-bearer. Life Sci.
77:2703-16, 2005.
26.
Choudhuri
T, Pal S, Das T & Sa G. Curcumin selectively induces apoptosis in
deregulated cyclin D1 expressed cells at G2 phase of cell cycle in a
p53-dependent manner. J. Biol.
Chem. 280:20059-68,
2005 .
27.
Mandal D,
Lahiry L, Bhattacharyya A, Chattopadhyay S, Siddiqi M, Sa G and Das
T. Black tea protects thymocytes in tumor-bearers by differential
regulation of intracellular ROS in tumor cells and thymocytes. J.
Environ. Toxicol. Pathol. Oncol. 24:91-104, 2005.
28.
Bandyopadhyay S, Bhattacharyya A, Mallick A, Sen AK, Tripathi G,
Das T,
Sa G, Bhattacharya DK and Mandal C. Over expressed IgG2
antibodies against O-acetylated sialoglycoconjugates incapable of
proper effector functioning in childhood acute lymphoblastic leukemia.
Int.
Immunol.
17:177-91, 2005.
29.
Bhattacharyya A, Mandal D, Lahiry L, Sa G & Das T.
Black tea
protects immunocytes from tumor-induced apoptosis by changing Bcl-2/Bax
ratio. Cancer Lett 209: 147-154, 2004.
30.
Rayman P,
Wesa AK, Richmond AL, Das T, Biswas K, Storkus WJ, Tannenbaum C,
Novick A, Bukowksi R & Finke J. Effect of Renal Cell Carcinomas on the
Development of Type I T Cell Responses. Clinical Cancer Research
10: 6360-6366, 2004.
31.
Mandal D,
Lahiry L, Bhattacharyya A, Bhattacharyya A, Sa G & Das T.
Pharmacotherapeutics of tea: Proposed strategies and pharmacological
studies. Int J Tea Sci 3: 261-272, 2004.
32.
Finke JH,
Tannenbaum C, Storkus W, Rayman P, Das T, Biswas K, Richmond A, Moon
C, Thornton M, Gill I, Novick A & Bukowski R. Tumor-induced dysfunction in T
lymphocytes: increased sensitivity to apoptosis. Urologe A
43:131-132, 2004.
33.
Bhattacharyya A, Chattopadhyay S, Choudhury T, Banerjee A, Sa G &
Das
T.
Apoptogenic effects of black tea on Ehrlich's ascites carcinoma cell.
Carcinogenesis 24: 75-80, 2003.
34.
Molto L,
Rayman P, Paszkiewicz-Kozik E, Thornton M, Reese L, Thomas JC, Das T,
Kudo D, Bukowski R, Finke J & Tannenbaum C. The Bcl-2 transgene protects T
cells from renal cell carcinoma-mediated apoptosis. Clin Cancer Res.
9: 4060-4068, 2003.
35.
Bhattacharyya A, Sa G, Das T & Siddiqi M. Black tea-induced cellular
survival: Evidence for reduced toxicity and enhanced immunity in mice under
stress. Int J Tea Sci 2: 34-39, 2003,
36.
Choudhuri
T, Pal S, Agwarwal ML, Das T
and
Sa G. Curcumin induces apoptosis in human breast cancer cells through
p53-dependent Bax induction. FEBS Lett. 512, 334-340,
2002.
37.
Das T,
Sa G, Chattopadhyay S
and
Ray PK. Protein A-induced apoptosis of cancer cells is affected by soluble
immune mediators. Cancer Immunol. Immunotherapy 51,
376-380, 2002.
38.
Chattopadhyay S, Das T, Sa G,
and
Ray PK. Protein A-activated macrophages induce apoptosis in Ehrlich's
ascites carcinoma through a nitric oxide-dependent pathway. Apoptosis
7, 49-57, 2002.
39.
Ghosh S,
Bhattacharyya S, Sirkar M, Sa G, Das T, Majumdar D, Roy S
and
Majumdar S. (2002) Leishmania donovani suppresses activated protein 1
and NF-kappaB activation in host macrophages via ceramide generation:
Involvement of extracellular signal-regulated kinase. Infect Immun
70, 6828-6838.
40.
Pal S,
Choudhuri T, Chattopadhyay S, Bhattacharya A, Datta GK, Das T & Sa G.
Mechanisms of curcumin-induced apoptosis of Ehrlich's ascites carcinoma
cells. Biochem Biophys Res Commun 288: 658-665, 2001.
41.
Ray PK,
Das T, Sa G, Ghosh AK & Chattopadhyay S. Protection of apoptotic
cell death by Protein A. Apoptosis 5: 509-514, 2000.
42.
Das T,
Sa G, Subbulakshmi V, Subramaniam S, Sen PC, Biswas S & Ray PK. Protein
A-activated rat spleenic lymphocyte proliferation involves tyrosine kinase
- phospholipase C - protein kinase C pathway. Immunopharmacol.
Immunotoxicol. 22: 75-90, 2000.
43.
Ghosh AK,
Jana S, Das T, Sa G, Mondal N & Ray PK. Protection by Protein A of
apoptotic death caused by anti-AIDS drug zidovudine. Biochem. Biophys.
Res. Commun. 264: 601-604, 1999.
44.
Das T,
Sa G & Ray PK. Mechanisms of Protein A superantigen-induced signal
transduction for proliferation of mouse B cells. Immunol. Lett.
70: 43-51, 1999.
45.
Das T,
Sa G, Sinha P, & Ray PK.
Induction
of cell proliferation and apoptosis: dependence on the dose of the inducer.
Biochem. Biophys. Res. Commun. 260: 105-110, 1999.
46.
Sinha P,
Ghosh AK, Das T, Sa G & Ray PK. Protein A of S. aureus evokes
Th1 type response in mice. Immunol. Lett. 67: 157-165, 1999.
47.
Sa G &
Das T. Basic FGF stimulates phospholipase A2, phospholipase
C-g1
and phospholipase D through distinguishable signaling mechanisms.
Mol. Cell. Biochem. 198: 19-30, 1999.
48.
Ghosh AK,
Sinha P, Das T, Sa G, & Ray PK. S. aureus superantigen
Protein A expand CD4+/CD19+/CD34+ cells in mice- a potential immunorestorer.
Biochem. Biophys. Res. Commun. 256: 142-146, 1999.
49.
Subbulakshmi V, Ghosh AK, Das T, & Ray PK. Mechanism of Protein
A-induces amelioration of toxicity of anti-AIDS drug. Biochem. Biophys.
Res. Commun. 250: 15-21, 1998.
50.
Goenka S,
Das T, Sa G, & Ray PK. Protein A induces NO production: Involvement
of tyrosine kinase, phospholipae C and Protein kinase C. Biochem.
Biophys. Res. Commun. 250: 425-429, 1998.
51.
Baek KJ,
Das T, Gray CD, Desai S, Hwang K-C, Gacchui R, Ludwing M & M-J. A 50
kDa protein modulates guanine nucleotide binding of transglutaminase II.
Biochemistry 35: 2651-2657, 1996.
52.
Nakaoka
H, Perez DM, Baek K-J, Das T, Husain A, Misono K, Im M-J & Graham RM.
Gh: A GTP-binding protein with transglutaminase activity and receptor
signaling function. Science 264: 1593-1596, 1994.
53.
Baek K-J,
Das T, Gray CD, Antar S, Murugesan G & Im M-J. Evidence that the Gh
protein is a signal mediator from
a1-adrenoceptor
to a phospholipase C: I. Identification of
a1-adrenoceptor-coupled
Gh family and purification of Gh7 from bovine heart. J.
Biol. Chem. 268: 27390-27397, 1993.
54.
Das T,
Baek K-J, Gray C & Im M-J. Evidence that the Gh protein is a
signal mediator from
a1-adrenoceptor
to a phospholipase C: II. Purification and characterization of a Gh-coupled
69-kDa phospholipase C and reconstitution of
a1-adrenoceptor,
Gh family and phospholipase C. J. Biol. Chem. 268:
27398-27405, 1993.
55.
Sa G,
Das T & Mukherjea M. Characterization and binding properties of human
fetal lung fatty acid binding proteins. Mol. Cell. Biochem. 129:
67-75, 1993.
56.
Das T,
Sa G & Mukherjea M. Characterization of cardiac fatty acid binding protein
from human placenta: Comparison with placenta hepatic proteins. Eur.
J. Biochem. 211: 725-730, 1993.
57.
Sa G,
Das T & Mukherjea M. The evaluation of lung maturity by lecithin, L/S
and PG/PI ratios in human fetus. Med. Sci. Res. 21: 365-366,
1993.
58.
Ghosh PK,
Das T, Sa G & Mukherjea M. Gestational variation in the fluidity of
human placental brush border membrane: Assessed by lyposomal transfer
study. Med. Sci. Res. 20: 705-706, 1992.
59.
Mukhopadhyay D, Das T, Sa G, Ghosh PK & Mukherjea M. Isolation of
fatty acid binding protein from developing human fetal brain. Med. Sci.
Res. 20: 641-642, 1992.
60.
Das T,
Sa G, Bandhopadhyay AK & Mukherjea M. Relationship between fatty acid
binding proteins, acetyl CoA formation and fatty acid synthesis in
developing human placenta. J. Biosci. 16: 235-242, 1991.
61.
Sa G,
Das T & Mukherjea M. Relationship between fatty acid synthesis,
transport and total lipid content during human fetal lung development.
Indian J. Biochem. Biophys. 27: 43-47, 1990.
62.
Das T,
Sa G, Ghosh PK, Mukhopadhyay D & Mukherjea M. Isolation of fatty acid
binding protein from human fetal intestine and heart: Comparison with
corresponding hepatic proteins. Med. Sci. Res. 17: 985-986,
1989.
63.
Sa G,
Das T & Mukherjea M. Purification and characterization of fatty acid
binding protein from human fetal lung. Exp. Lung Res. 15:
619-632, 1989.
64.
Das T,
Sa G & Mukherjea M. Human fetal liver fatty acid binding proteins. Role on
glucose 6 phosphate dehydrogenase activity. Biochim. Biophys. Acta
1002: 164-172, 1989.
65.
Das T,
Sa G & Mukherjea M. Purification and characterization of fatty acid binding
protein from developing human placenta. Lipids 23:
528-533, 1988.
66.
Sa G,
Das T & Mukherjea M. Ontogenic profile and properties of glucose 6
phosphate dehydrogenase in human fetal tissues. Indian J. Biochem.
Biophys. 23: 135-137, 1987.
67.
Das T,
Chaudhury I & Mukherjea M. Effect of polyamines on RNA synthesis in human
fetal brain. Indian Biologist 18: 40-41, 1986.
68.
Das T
& Mukherjea M. Isolation of fatty acid binding protein from developing human
placenta and fetal liver.
IRCS Med.
Sci.
14:
211, 1986.
Book
Chapter / Reviews etc.
1.
Das T,
Sa G, Saha S, Mukherjee S, Mazumdar M and Mukherjee S. p53, a tumor
suppressor at the crossroads of the oncogenic networks in cancer: Targeting
the ‘guardian of the genome’.
Prospective in Cytolology &
Genet.
14,
(In press) (2010)
2.
Sa G,
Das T,
Roy P, Banerjee S and Chakraborty J.
Oncogenes as
molecular target for curcumin-induced cancer cell apoptosis.
Prospective in
Cytology & Genetics
14, (In press)
(2010)
3.
Mohanty S, Adhikary A,
Chakrabarty S,
Sa G and
Das T.
Operation ‘p53 Hunt’ to combat cancer: Theaflavins in action.
Frontiers in Biosciences
(Invited submission) (2010)
4.
Hossain DMS, Bhattacharyya S,
Das T,
and Sa G.
Curcumin:
The multi-targeted
therapy for cancer regression.
Frontiers in Biosciences
(Invited submission) (2010)
5.
Das T,
Sa G, Saha B and Das
K.
Multifocal signal modulation therapy of cancer: Ancient weapon, modern
targets. Mol. Cell. Biochem.
336,
85–95
(2010)
6.
Sa G,
Das T,
Banerjee S and Chakrabarty J. Curcumin: From exotic spice to modern
anticancer drug. A A J Med Sci. 3, 21-37 (2010)
7.
Parton M,
Das T, Sa G, Finke J, Eisen T, Tannenbaum C. Tumour Necrosis Factor -
Misnomer and Therapeutic Target. In: Targeted Therapy for Renal Cell
Carcinoma (Ed: Dr. R Bukowski). Springer Publishing Company,
New York, NY. Chapter 19, 425-488 (2009)
8.
Das T,
Sa G, Chattopadhyay S and Saha B. Black tea: The Future Panacea for Cancer.
A A J Med Sci. 1, 70-83 (2008)
9.
Das T,
Sa G and Siddiqi M. Potential targets of tea polyphenols in cancer
prevention: significance in angiogenesis, metastasis and apoptosis as well
as in protection of host defense system. In: Protective effects of tea
on human health (Eds. J Weisberger, N K Jain and M Siddiqi) Cabi
London, 76-90, 2006
10.
Bhattacharyya A, Chattopadhyay S and
Das T.
Tea: A journey across time from beverage to anticancer agent. In:
Emerging Pollutants: Impact on Agriculture, Environment and Health
(Ed. De A and Gupta S), Allied Publishers, India chapter 15, 157-163,
2006
11.
Lahiry
L, Mandal D, Bhattacharyya A, Sa G & Das T. Cancer prevention by
cancer regression and rejuvenation of host defense system: Dual role of tea.
In: Tea Therapeutics (Eds. B Banerjee & TC Chaudhury) Science
Publishers, INC., USA, UK, pp 89-112, 2005
12.
Ray PK,
Das T
& Sa G. How to activate intrinsic stress resistance mechanisms to obtain
therapeutic benefit. In:
Cell and
Molecular Responses to Stress
(ed. Storey JM and Storey KB) Elsevier Science, USA,
Volume 2,
Chapter 14, 2001
13.
Ray PK,
Das T,
Subbulakshmi V, Ghosh AK, Sa G,
Sinha P &
Sengupta J. Immunopharmacologic modulation of host response to increase
therapeutic index of drugs. In:
Immunopharmacology: Strategies for Immunotherapy
(Ed. SN
Upadhyay), Norosa Publishing House, New Delhi, India, pp 72-84, 1999.
14.
Ray PK &
Das T.
Molecular adaptation to toxic chemicals and drugs.
Adv.
Organ Biol.
6:
251-265, 1998.
15.
Ray PK, Goenka S,
Das T,
Sa G, Sinha P & Srivastava M. Role of nitric oxide in immune function and
amelioration of toxicity and carcinogenicity of drugs and chemicals. In:
Biological oxidants and anti-oxidants: Molecular mechanisms and health
effects.
(Ed. L Packer) AOCS Press, USA, Ch.7: 42-53, 1998.
16.
Ray PK, Datta PK,
Das T,
Srivastava M & V. Subbulakshmi M. Structural analysis of Protein A to
localize immunomodulatory motifs. In
Immunomodulation,
(Ed. S.N. Upadhyay) Narosa Press, India, 101-110, 1997.
Patents
1. Sa G
& Das T. A process for producing therapeutically active pure curcumin from
Curcuma longa Linn. The gazette of India, Part III,
Section 2, August 30, 2003
|